S. Takkal SRL
S. Takkal reported total assets of 593,750 € at the end of the 2025 financial year (annual accounts filed with the NBB on 20 Mar 2026).
By total assets for 2025, S. Takkal ranks in the top half of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of S. Takkal shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +357 % Total assets +298 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
S. Takkal's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 20 Mar 2026
- Year ended 30 Sep 2024filed on 12 May 2025
- Year ended 30 Sep 2023filed on 29 Apr 2024
S. Takkal's financial analysis
- Solvency77.5%sector median: 67.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of S. Takkal
S. Takkal's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0798.310.988
- VAT number
- BE0798310988
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 10 Feb 2023
- Registered office
- 1030 Schaerbeek
- Latest accounts
- 2025 · filed on 20 Mar 2026
- Activity
- Medical specialists activities (NACE 86220)
S. Takkal (SRL) has been based in Schaerbeek since 2023, active in: medical specialists activities. For 2025, it reports a net profit of 180,438 € and equity of 460,253 €; its revenue is not published. Its solvency stands at 77.5%, above the median of its sector (67.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to S. Takkal
Companies in the same business, of comparable size and area, outside its group.
- Docteur Pierre Origer Medical specialists activities Anderlecht · balance sheet 593,176 €
- Dr. Heylbroeck Ph., NKO Medical specialists activities Sint-Martens-Latem · balance sheet 594,006 €
- Annelies Louwagie Medical specialists activities Genk · balance sheet 593,268 €
- Ophtalmocare Medical specialists activities Waterloo · balance sheet 594,643 €
- Neuroprakt Medical specialists activities Hasselt · balance sheet 592,605 €
- Dr LEROY JOHANNE Medical specialists activities Nivelles · balance sheet 592,369 €
- Dr DONY Medical specialists activities Mont-Saint-Guibert · balance sheet 578,500 €
- Bouazza médical Medical specialists activities Anhée · balance sheet 591,907 €
Frequently asked questions about S. Takkal
What is the revenue of S. Takkal?
S. Takkal files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of S. Takkal?
In Belgium, the VAT number is the company number prefixed with BE: BE0798310988 for S. Takkal, if the company is VAT-registered. Its company number (CBE) is 0798.310.988.
Where is the registered office of S. Takkal?
According to the CBE register, the registered office of S. Takkal is in 1030 Schaerbeek.
What is the equity of S. Takkal?
At the close of the 2025 financial year, the equity of S. Takkal amounts to 460,253 €, a solvency of 77.5% of total assets.
Who manages S. Takkal?
The register lists 1 active mandates at S. Takkal. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is S. Takkal within its sector?
By total assets for 2025, S. Takkal ranks in the top half of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year.
The full file of S. Takkal
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →